SAN DIEGO, April 22 /PRNewswire-FirstCall/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced that its underwriters have exercised their over-allotment option to purchase additional shares of common stock in connection with BioMed's previously announced follow-on offering that priced on April 17, 2008. In total, the company sold 6,129,000 shares of common stock, raising gross offering proceeds of approximately $156.3 million.
The underwriters for the offering are Raymond James & Associates, Inc., Morgan Stanley & Co. Incorporated, Wachovia Capital Markets, LLC, KeyBanc Capital Markets Inc., Robert W. Baird & Co. Incorporated, Credit Suisse Securities (USA) LLC, RBC Capital Markets Corporation and Stifel, Nicolaus & Company, Incorporated.
The registration statement relating to these securities has become effective by rule of the Securities and Exchange Commission. This press release shall not constitute an offer to sell or the solicitation of an offer to buy any of BioMed's common stock, nor shall there be any sale of such common stock in any state in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of such state. The offering of BioMed's common stock is being made only by means of a prospectus and a related prospectus supplement, copies of which may be obtained by contacting Raymond James & Associates, Inc., 880 Carillon Parkway, St. Petersburg, FL 33716, or by calling toll-free at 1 (800) 248-8863.
About BioMed Realty Trust
BioMed Realty Trust, Inc. is a real estate investment trust (REIT)
focused on Providing Real Estate to the Life Science Industry(R). The
company's tenants primarily include biotechnology and pharmaceutical
|SOURCE BioMed Realty Trust, Inc.|
Copyright©2008 PR Newswire.
All rights reserved